Detailed Information on Publication Record
2017
MAGERI: Computational pipeline for molecular-barcoded targeted resequencing
SHUGAY, Mikhail, A.R. ZARETSKY, D.A. SHAGIN, I.A. SHAGINA, I.A. VOLCHENKOV et. al.Basic information
Original name
MAGERI: Computational pipeline for molecular-barcoded targeted resequencing
Authors
SHUGAY, Mikhail (643 Russian Federation, belonging to the institution), A.R. ZARETSKY (643 Russian Federation), D.A. SHAGIN (643 Russian Federation), I.A. SHAGINA (643 Russian Federation), I.A. VOLCHENKOV (643 Russian Federation), A.A. SHELENKOV (643 Russian Federation), Mikhail LEBEDIN (643 Russian Federation, belonging to the institution), D.V. BAGAEV (643 Russian Federation), S. LUKYANOV (643 Russian Federation) and Dmitriy CHUDAKOV (643 Russian Federation, guarantor, belonging to the institution)
Edition
PLoS Computational Biology, SAN FRANCISCO, PUBLIC LIBRARY SCIENCE, 2017, 1553-734X
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10609 Biochemical research methods
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 3.955
RIV identification code
RIV/00216224:14740/17:00100339
Organization unit
Central European Institute of Technology
UT WoS
000402889500008
Keywords in English
CIRCULATING TUMOR DNA; THERAPEUTIC RESPONSE; IMMUNE REPERTOIRES; COLORECTAL-CANCER; SOMATIC MUTATION; SEQUENCING ERROR; RARE MUTATIONS; SOLID TUMORS; GENOME; PLASMA
Tags
International impact, Reviewed
Změněno: 13/3/2018 14:07, Mgr. Pavla Foltynová, Ph.D.
Abstract
V originále
Unique molecular identifiers (UMIs) show outstanding performance in targeted high-throughput resequencing, being the most promising approach for the accurate identification of rare variants in complex DNA samples. This approach has application in multiple areas, including cancer diagnostics, thus demanding dedicated software and algorithms. Here we introduce MAGERI, a computational pipeline that efficiently handles all caveats of UMI-based analysis to obtain high-fidelity mutation profiles and call ultra-rare variants. Using an extensive set of benchmark datasets including gold-standard biological samples with known variant frequencies, cell-free DNA from tumor patient blood samples and publicly available UMI-encoded datasets we demonstrate that our method is both robust and efficient in calling rare variants. The versatility of our software is supported by accurate results obtained for both tumor DNA and viral RNA samples in datasets prepared using three different UMI-based protocols.
Links
LQ1601, research and development project |
| ||
633592, interní kód MU |
|